Literature DB >> 24558203

Control of VWF A2 domain stability and ADAMTS13 access to the scissile bond of full-length VWF.

Christopher J Lynch1, David A Lane, Brenda M Luken.   

Abstract

Rheological shear forces in the blood trigger von Willebrand factor (VWF) unfolding which exposes the Y1605-M1606 scissile bond within the VWF A2 domain for cleavage by ADAMTS13. The VWF A2 domain contains 2 structural features that provide it with stability: a vicinal disulphide bond and a Ca(2+)-binding site (CBS). We investigated how these 2 structural features interplay to determine stability and regulate the exposure of the scissile bond in full-length VWF. We have used differential scanning fluorimetry together with site-directed mutagenesis of residues involved in both the vicinal disulphide bond and the CBS to demonstrate that both of these sites contribute to stability against thermal unfolding of the isolated VWF A2 domain. Moreover, we show that the combination of site mutations can result in increased susceptibility of FL-VWF to proteolysis by ADAMTS13, even in the absence of an agent (such as urea) required to induce unfolding. These studies demonstrate that VWF A2 domain stability provided by its 2 structural elements (vicinal disulphide bond and CBS) is a key protective determinant against FL-VWF cleavage by ADAMTS13. They suggest a 2-step mechanism for VWF A2 domain unfolding.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24558203      PMCID: PMC3990914          DOI: 10.1182/blood-2013-11-538173

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  20 in total

1.  Mechanisms by which von Willebrand disease mutations destabilize the A2 domain.

Authors:  Amy J Xu; Timothy A Springer
Journal:  J Biol Chem       Date:  2013-01-15       Impact factor: 5.157

Review 2.  Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor.

Authors:  J E Sadler; U Budde; J C J Eikenboom; E J Favaloro; F G H Hill; L Holmberg; J Ingerslev; C A Lee; D Lillicrap; P M Mannucci; C Mazurier; D Meyer; W L Nichols; M Nishino; I R Peake; F Rodeghiero; R Schneppenheim; Z M Ruggeri; A Srivastava; R R Montgomery; A B Federici
Journal:  J Thromb Haemost       Date:  2006-08-02       Impact factor: 5.824

3.  Conformational stability and domain unfolding of the Von Willebrand factor A domains.

Authors:  Matthew Auton; Miguel A Cruz; Joel Moake
Journal:  J Mol Biol       Date:  2006-10-25       Impact factor: 5.469

4.  Mechanoenzymatic cleavage of the ultralarge vascular protein von Willebrand factor.

Authors:  Xiaohui Zhang; Kenneth Halvorsen; Cheng-Zhong Zhang; Wesley P Wong; Timothy A Springer
Journal:  Science       Date:  2009-06-05       Impact factor: 47.728

5.  Structural specializations of A2, a force-sensing domain in the ultralarge vascular protein von Willebrand factor.

Authors:  Qing Zhang; Yan-Feng Zhou; Cheng-Zhong Zhang; Xiaohui Zhang; Chafen Lu; Timothy A Springer
Journal:  Proc Natl Acad Sci U S A       Date:  2009-05-21       Impact factor: 11.205

6.  Identification of disulfide-bridged substructures within human von Willebrand factor.

Authors:  T Marti; S J Rösselet; K Titani; K A Walsh
Journal:  Biochemistry       Date:  1987-12-15       Impact factor: 3.162

7.  Physiologic cleavage of von Willebrand factor by a plasma protease is dependent on its conformation and requires calcium ion.

Authors:  H M Tsai
Journal:  Blood       Date:  1996-05-15       Impact factor: 22.113

Review 8.  Biochemistry and genetics of von Willebrand factor.

Authors:  J E Sadler
Journal:  Annu Rev Biochem       Date:  1998       Impact factor: 23.643

9.  Analysis of intracellular storage and regulated secretion of 3 von Willebrand disease-causing variants of von Willebrand factor.

Authors:  Grégoire Michaux; Lindsay J Hewlett; Sarah L Messenger; Anne C Goodeve; Ian R Peake; Martina E Daly; Daniel F Cutler
Journal:  Blood       Date:  2003-06-05       Impact factor: 22.113

Review 10.  Unraveling the scissile bond: how ADAMTS13 recognizes and cleaves von Willebrand factor.

Authors:  James T B Crawley; Rens de Groot; Yaozu Xiang; Brenda M Luken; David A Lane
Journal:  Blood       Date:  2011-06-29       Impact factor: 22.113

View more
  15 in total

Review 1.  ADAMTS13 and von Willebrand factor in thrombotic thrombocytopenic purpura.

Authors:  X Long Zheng
Journal:  Annu Rev Med       Date:  2015       Impact factor: 13.739

2.  Role of calcium in regulating the intra- and extracellular cleavage of von Willebrand factor by the protease ADAMTS13.

Authors:  Shobhit Gogia; Anju Kelkar; Changjie Zhang; Kannayakanahalli M Dayananda; Sriram Neelamegham
Journal:  Blood Adv       Date:  2017-10-20

3.  Conformational activation of ADAMTS13.

Authors:  Kieron South; Brenda M Luken; James T B Crawley; Rebecca Phillips; Mari Thomas; Richard F Collins; Louis Deforche; Karen Vanhoorelbeke; David A Lane
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-15       Impact factor: 11.205

Review 4.  Acquired Von Willebrand Syndrome (AVWS) in cardiovascular disease: a state of the art review for clinicians.

Authors:  Radha Mehta; Muhammad Athar; Sameh Girgis; Atif Hassan; Richard C Becker
Journal:  J Thromb Thrombolysis       Date:  2019-07       Impact factor: 2.300

Review 5.  ADAMTS13 conformations and mechanism of inhibition in immune thrombotic thrombocytopenic purpura.

Authors:  Konstantine Halkidis; X Long Zheng
Journal:  J Thromb Haemost       Date:  2022-08-03       Impact factor: 16.036

6.  N-linked glycan stabilization of the VWF A2 domain.

Authors:  Christopher J Lynch; David A Lane
Journal:  Blood       Date:  2016-01-14       Impact factor: 22.113

7.  The role of the ADAMTS13 cysteine-rich domain in VWF binding and proteolysis.

Authors:  Rens de Groot; David A Lane; James T B Crawley
Journal:  Blood       Date:  2015-01-06       Impact factor: 22.113

8.  A common mechanism by which type 2A von Willebrand disease mutations enhance ADAMTS13 proteolysis revealed with a von Willebrand factor A2 domain FRET construct.

Authors:  Christopher J Lynch; Adam D Cawte; Carolyn M Millar; David Rueda; David A Lane
Journal:  PLoS One       Date:  2017-11-29       Impact factor: 3.240

9.  High throughput protease profiling comprehensively defines active site specificity for thrombin and ADAMTS13.

Authors:  Colin A Kretz; Kärt Tomberg; Alexander Van Esbroeck; Andrew Yee; David Ginsburg
Journal:  Sci Rep       Date:  2018-02-12       Impact factor: 4.379

Review 10.  Role of fluid shear stress in regulating VWF structure, function and related blood disorders.

Authors:  Shobhit Gogia; Sriram Neelamegham
Journal:  Biorheology       Date:  2015       Impact factor: 1.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.